摘要
[目的]探讨急性进展型脑梗死的治疗方法。[方法]86例急性进展型脑梗死患者随机分为治疗组与对照组各43例。治疗组用东菱克栓酶静脉滴注;对照组低分子肝素;两组病人均给予丹参和胞二磷胆碱作为基础治疗。[结果]从治疗后第3天开始,治疗组ESS(欧洲卒中临床神经功能缺损评分)评分优于对照组(P<0.05),至治疗后第14d,两组ESS评分相差更显著(P<0.01)。治疗组血纤维蛋白原水平降低显著,不良反应轻微。[结论]东菱克栓酶可比较迅速地终止急性进展型脑梗死患者的病情进展,明显加快其神经功能的康复,而且治疗时间窗宽广,安全性良好。
[Objective]To explore the method for progressive cerebral infarction.[Method]86 cases were randomly divided into treatment group(1)and control group(2)with 43 cases in each;group 1 took Batroxiobin;group 2,low molecular heparin 5000U;both took the basic therapy of Red Sage and CDPC.[Result]From the 3rd day,the ESS score of group 1 was higher than group 2;to 14th day,the discrepancy was more marked.In group 1,the blood fibrinogen was obviously lowered,with slight side effect.[Conclusion]Batroxiobin can quickly stop acute progressive cerebral infarction and markedly speed up nerve function recovery,with broader treatment time window and good safety.
出处
《浙江中医药大学学报》
CAS
2010年第5期699-700,共2页
Journal of Zhejiang Chinese Medical University
关键词
脑梗死
东菱克栓酶
低分子肝素
降纤治疗
cerebral infarction
Batroxiobin
low molecular heparin
fibrin-reduction
